Paragon 28 inc

美股醫療保健

FNA 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

公司發布財報數據季度不足,尚無法提供評分

FNA 近期報酬表現

7.78%

Paragon 28 inc

2.92%

同產業平均

1.26%

S&P500

與 FNA 同產業的標的表現

  • TMCI Treace medical concepts inc
    價值 4 分趨勢 2 分波段 2 分籌碼 3 分股利 1 分
    查看更多

FNA 公司資訊

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company's suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient's anatomical and surgical requirements.

FNA 股價